CAROLINE ELISTIN: Open Payments
NPI 1083872758 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$8,955 in 65 payments from 26 companies in 2025. Trend: 2023 $672 · 2024 $7,187 · 2025 $8,955
Speaker / faculty: $3,705Travel & lodging: $3,469Food & beverage: $1,781
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 15 | $7,254 |
| Janssen Biotech, Inc. | 6 | $211 |
| Insulet Corporation | 1 | $169 |
| Boston Scientific Corporation | 1 | $147 |
| E.R. Squibb & Sons, L.L.C. | 2 | $118 |
| ViiV Healthcare Company | 1 | $118 |
| Caris MPI, Inc. | 3 | $108 |
| Incyte Corporation | 4 | $92 |
| Novartis Pharmaceuticals Corporation | 4 | $83 |
| Eisai Inc. | 4 | $78 |
Products named: KEYTRUDA, RYBREVANT, OMNIPOD, WATCHMAN FLX, MI CANCER SEEK, Lenvima, LONSURF, MONJUVI.
Industry payments across FL — which companies pay providers there.
